Mr Mrs Miss Ms Dr Other

Dr
Daniel
Woollaston

Partner & Patent Attorney

Leeds Office York Office

Chemistry

Telephone. +44(0) 113 233 0100
Mobile. +44(0) 738 487 7685
Email. [email protected]
Vcard

Experience

Since joining HGF in 2010, much of Daniel’s work has concerned the drafting and prosecuting of patent applications across a broad spectrum of chemical sciences, but particularly in the fields of pharmaceuticals, medicinal chemistry, organic chemistry, graphene and other 2D materials, chemical engineering, carbon capture, dyes, agrochemicals, and resins for use in 3D printers. Daniel also has experience in advising on freedom to operate issues.

Daniel has formulated complex IP strategies for several award winning UK pharmaceutical companies.

He has worked extensively with a number of UK Russell Group universities for whom he has provided patentability opinions and drafted and prosecuted to grant worldwide patent applications in a range of technically complex chemistry related subject matters.

Specialisms

Industries

Services

Qualifications

Patent Attorney

Chartered (UK)
Europe

MCHEM

University of Oxford

PHD

Organic Chemistry; University of Oxford

Conferences: 2021

January 14th 2021

HGF IP in Healthcare Virtual Conference 2021

Speaker

Event details

Related News

Managing Intellectual Property IP Stars 2023

After months of research, Managing IP has published the IP Stars list for 2023. HGF is delighted to have 23 attorneys from England, Scotland, Ireland, Netherlands and Germany recognised and …

Read article

Profiting from Innovation Within Product Platforms

Innovative businesses should seek to maximise the value they obtain from working collaboratively within a product platform ecosystem. A well-defined IP strategy can help achieve this while increasing total innovation …

Read article
Event - 25th May 2023

New seminar series in Salzburg, Dresden and Hamburg

HGF is organising a new German-speaking seminar series in Salzburg, Dresden, and Hamburg starting May 25 2023. Dates May 25, 2023 at 17:30 – Salzburg June 1 2023 at 17:30 …

Event details

Can Artificial Intelligence save the NHS?

In recent months, it has been almost impossible to escape reports of the staffing crisis in the NHS and the impact this is having on the services the NHS can …

Read article

Spotting innovation in digital health – and can you patent it?

Intellectual Property (IP) can add significant value to your business, providing a competitive edge over the market, as well as demonstrating sound business planning to help secure investment. There are …

Read article

Innovation at the heart of UK medtech strategy

The UK Department of Health and Social Care has recently published the government’s first ever medical technology strategy in an effort to accelerate access to innovative technologies. The strategy document …

Read article

How medtech start-ups can supercharge their IP for fundraising

Why is IP important for fundraising? Intellectual property (IP) rights underpin the value of most medtech start-up companies. IP rights include patents, design rights, trade marks, copyright and trade secrets …

Read article

What is EUDAMED and how will it affect your IP strategy?

The “European database on medical devices”, or “EUDAMED”, is the EU’s IT system created by the new Medical Devices Regulation (MDR) and In Vitro Diagnostics Medical Devices Regulation (IVDR). When …

Read article
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.

Contact us